Stouffer GA - Search Results

1

Therapeutic strategies for thrombosis: new targets and approaches.

Mackman N, Bergmeier W, Stouffer GA, Weitz JI. Mackman N, et al. Among authors: stouffer ga. Nat Rev Drug Discov. 2020 May;19(5):333-352. doi: 10.1038/s41573-020-0061-0. Epub 2020 Mar 4. Nat Rev Drug Discov. 2020. PMID: 32132678 Review.

2

Dual Anticoagulant and Antiplatelet Therapy for Coronary Artery Disease and Peripheral Artery Disease Patients.

Mackman N, Spronk HMH, Stouffer GA, Ten Cate H. Mackman N, et al. Among authors: stouffer ga. Arterioscler Thromb Vasc Biol. 2018 Apr;38(4):726-732. doi: 10.1161/ATVBAHA.117.310048. Epub 2018 Feb 15. Arterioscler Thromb Vasc Biol. 2018. PMID: 29449336 Free PMC article. Review. No abstract available.

3

Safety of adjunctive intracoronary thrombolytic therapy during complex percutaneous coronary intervention: initial experience with intracoronary tenecteplase.

Kelly RV, Crouch E, Krumnacher H, Cohen MG, Stouffer GA. Kelly RV, et al. Among authors: stouffer ga. Catheter Cardiovasc Interv. 2005 Nov;66(3):327-32. doi: 10.1002/ccd.20521. Catheter Cardiovasc Interv. 2005. PMID: 16208711

4

Optimal use of platelet glycoprotein IIb/IIIa receptor antagonists in patients undergoing percutaneous coronary interventions.

Starnes HB, Patel AA, Stouffer GA. Starnes HB, et al. Among authors: stouffer ga. Drugs. 2011 Oct 22;71(15):2009-30. doi: 10.2165/11595010-000000000-00000. Drugs. 2011. PMID: 21985168 Review.

5

Review of clopidogrel dose escalation in the current era of potent P2Y12 inhibitors.

Howell LA, Stouffer GA, Polasek M, Rossi JS. Howell LA, et al. Among authors: stouffer ga. Expert Rev Clin Pharmacol. 2015;8(4):411-21. doi: 10.1586/17512433.2015.1057571. Epub 2015 Jun 19. Expert Rev Clin Pharmacol. 2015. PMID: 26092217 Review.

6

Predictors, treatment, and outcomes of STEMI occurring in hospitalized patients.

Dai X, Kaul P, Smith SC Jr, Stouffer GA. Dai X, et al. Among authors: stouffer ga. Nat Rev Cardiol. 2016 Mar;13(3):148-54. doi: 10.1038/nrcardio.2015.165. Epub 2015 Nov 3. Nat Rev Cardiol. 2016. PMID: 26525542 Review.

7

CYP2C19-guided antiplatelet therapy: a cost-effectiveness analysis of 30-day and 1-year outcomes following percutaneous coronary intervention.

Borse MS, Dong OM, Polasek MJ, Farley JF, Stouffer GA, Lee CR. Borse MS, et al. Among authors: stouffer ga. Pharmacogenomics. 2017 Aug;18(12):1155-1166. doi: 10.2217/pgs-2017-0075. Epub 2017 Jul 26. Pharmacogenomics. 2017. PMID: 28745582

8

Clinical outcomes of CYP2C19 genotype-guided antiplatelet therapy: existing evidence and future directions.

Klein MD, Lee CR, Stouffer GA. Klein MD, et al. Among authors: stouffer ga. Pharmacogenomics. 2018 Aug 1;19(13):1039-1046. doi: 10.2217/pgs-2018-0072. Epub 2018 Jul 20. Pharmacogenomics. 2018. PMID: 30028231 Review.

9

Clinical Utility of CYP2C19 Genotyping to Guide Antiplatelet Therapy in Patients With an Acute Coronary Syndrome or Undergoing Percutaneous Coronary Intervention.

Klein MD, Williams AK, Lee CR, Stouffer GA. Klein MD, et al. Among authors: stouffer ga. Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):647-652. doi: 10.1161/ATVBAHA.118.311963. Arterioscler Thromb Vasc Biol. 2019. PMID: 30760018 Free article. Review.

10

CYP2C19 Genotype-Guided Antiplatelet Therapy and 30-Day Outcomes After Percutaneous Coronary Intervention.

Williams AK, Klein MD, Martin J, Weck KE, Rossi JS, Stouffer GA, Lee CR. Williams AK, et al. Among authors: stouffer ga. Circ Genom Precis Med. 2019 Feb;12(2):e002441. doi: 10.1161/CIRCGEN.119.002441. Circ Genom Precis Med. 2019. PMID: 30779635 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

234 results

Search Page

Filters